PlainRecalls
FDA Drug Critical Class I Terminated

Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05

Reported: April 17, 2019 Initiated: March 28, 2019 #D-1248-2019

Product Description

Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05

Reason for Recall

Presence of Particulate Matter: One vial was found to contain a hair.

Details

Recalling Firm
Aurobindo Pharma USA Inc.
Units Affected
88600 vials
Distribution
Product is being held at a distributor site in Mexico, Asheboro, NC, Charlotte, NC and Santa Teresa, NM and not further distributed in the U.S. Market.
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05. Recalled by Aurobindo Pharma USA Inc.. Units affected: 88600 vials.
Why was this product recalled?
Presence of Particulate Matter: One vial was found to contain a hair.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 17, 2019. Severity: Critical. Recall number: D-1248-2019.